发明名称 NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE WHICH HAS, AS SUBSTITUENT, PHENYL GROUP HAVING SULFONIC ACID ESTER STRUCTURE OR SULFONIC ACID AMIDE STRUCTURE INTRODUCED THEREIN AND HAS GLUCOCORTICOID RECEPTOR-BINDING ACTIVITY.
摘要 <p>Disclosed is a compound represented by the general formula (1) or a salt thereof, which is useful as a modulator for a glucocorticoid receptor. In the formula, R1 represents a lower alkyl group, a lower cycloalkyl group, an aryl group or the like; R2 represents a hydrogen atom, a lower alkyl group or the like; R3 represents a hydrogen atom, a lower alkyl group or the like; R4 and R5 independently represent a hydrogen atom, a lower alkyl group or the like; R6 represents a hydrogen atom, a lower alkyl group or the like; R7 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group or the like; W represents an oxygen atom, a sulfur atom, NR8 or the like; R8 represents a hydrogen atom, a lower alkyl group or the like; X represents an oxygen atom or a sulfur atom; Y represents a lower alkylene group or the like; Z represents an oxygen atom, a sulfur atom, NR9, OCO or OSO2; and R9 represents a hydrogen atom, a lower alkyl group or the like.</p>
申请公布号 MX2009012885(A) 申请公布日期 2009.12.10
申请号 MX20090012885 申请日期 2008.05.29
申请人 SANTEN PHARMACEUTICAL CO., LTD. 发明人 MAMORU MATSUDA;TOSHIYUKI MORI;MASATO NAGATSUKA;SACHIKO KOBAYASHI;MASATOMO KATO;MIWA TAKAI
分类号 C07D241/44;A61K31/498;A61P1/04;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P3/14;A61P5/50;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P17/02;A61P25/00;A61P25/18;A61P25/28;A61P27/06;A61P29/00;A61P37/00;A61P37/08;A61P43/00;C07D405/12;C07D409/12 主分类号 C07D241/44
代理机构 代理人
主权项
地址